- $9.87bn
- $15.67bn
- $6.25bn
- 76
- 42
- 50
- 56
2019 December 28th | 2021 January 2nd | R2022 January 1st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,238 | 2,907 | 3,810 | 5,218 | 6,251 |
Cost of Revenue | |||||
Gross Profit | 871 | 827 | 1,124 | 1,709 | 2,113 |
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,887 | 2,627 | 3,452 | 4,528 | 5,874 |
Operating Profit | 351 | 280 | 358 | 690 | 377 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 304 | 251 | 311 | 614 | -1.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 243 | 194 | 236 | 495 | -54.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 239 | 189 | 230 | 489 | -57.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 239 | 189 | 230 | 489 | -57.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.42 | 5.44 | 5.65 | 7.86 | 2.09 |
Dividends per Share | |||||
Special Dividends per Share |